BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7623546)

  • 21. Skin-Directed Therapies in Cutaneous T-Cell Lymphoma.
    Nguyen CV; Bohjanen KA
    Dermatol Clin; 2015 Oct; 33(4):683-96. PubMed ID: 26433841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcipotriol and regression in T-cell lymphoma of skin.
    Scott-Mackie P; Hickish T; Mortimer P; Sloane J; Cunningham D
    Lancet; 1993 Jul; 342(8864):172. PubMed ID: 8101264
    [No Abstract]   [Full Text] [Related]  

  • 23. Pegylated liposomal doxorubicin in the treatment of cutaneous T-cell lymphoma.
    Prince HM; Seymour JF; Ryan G; McCormack C
    J Am Acad Dermatol; 2001 Jan; 44(1):149-50. PubMed ID: 11148501
    [No Abstract]   [Full Text] [Related]  

  • 24. Pyoderma gangrenosum-like CD30+  cutaneous T-cell lymphoma in a patient with mycosis fungoides.
    Cozzani E; Scaparro M; Rongioletti F; Pierri I; Pimpinelli N; Parodi A
    J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):819-21. PubMed ID: 24576263
    [No Abstract]   [Full Text] [Related]  

  • 25. [Diagnosis and therapy of cutaneous T-cell lymphomas].
    Le T; Pierard GE; Pierard-Franchimont C; de la Brassinne M; Lapière CM
    Dermatologica; 1984; 169(2):60-5. PubMed ID: 6332749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isotretinoin and cutaneous helper T-cell lymphoma (mycosis fungoides).
    Kessler JF; Jones SE; Levine N; Lynch PJ; Booth AR; Meyskens FL
    Arch Dermatol; 1987 Feb; 123(2):201-4. PubMed ID: 2949706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Historical perspective on the use of retinoids in cutaneous T-cell lymphoma (CTCL).
    Burg G; Dummer R
    Clin Lymphoma; 2000 Nov; 1 Suppl 1():S41-4. PubMed ID: 11707863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A second case of dermatitis herpetiformis and cutaneous T-cell lymphoma.
    Sun G; Berthelot C; Duvic M
    Clin Exp Dermatol; 2008 Jul; 33(4):506-7. PubMed ID: 18346181
    [No Abstract]   [Full Text] [Related]  

  • 29. Poikilodermatous mycosis fungoides.
    Farley-Loftus R; Mandal R; Latkowski JA
    Dermatol Online J; 2010 Nov; 16(11):8. PubMed ID: 21163159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Results of the use of vitamin A and retinoids in cutaneous malignancies.
    Lippman SM; Meyskens FL
    Pharmacol Ther; 1989; 40(1):107-22. PubMed ID: 2645584
    [No Abstract]   [Full Text] [Related]  

  • 31. [Gemcitabine Monotherapy for Advanced Mycosis Fungoides--Two Case Reports and a Literature Review].
    Masuzawa M; Takasu H; Amoh Y
    Gan To Kagaku Ryoho; 2015 Dec; 42(13):2451-5. PubMed ID: 26809303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of mycosis fungoides.
    Cabanillas F; Gehan A
    N Engl J Med; 1990 May; 322(20):1470-1. PubMed ID: 2330018
    [No Abstract]   [Full Text] [Related]  

  • 33. Managing Patients with Cutaneous B-Cell and T-Cell Lymphomas Other Than Mycosis Fungoides.
    Kheterpal M; Mehta-Shah N; Virmani P; Myskowski PL; Moskowitz A; Horwitz SM
    Curr Hematol Malig Rep; 2016 Jun; 11(3):224-33. PubMed ID: 27101016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acquired cutis laxa associated with cutaneous angiocentric T-cell lymphoma.
    Chartier S; Faucher L; Tousignant J; Rochette L
    Int J Dermatol; 1997 Oct; 36(10):772-6. PubMed ID: 9372355
    [No Abstract]   [Full Text] [Related]  

  • 35. Use of isotretinoin and etretinate for the treatment of benign cutaneous neoplasia and cutaneous lymphoma in dogs.
    White SD; Rosychuk RA; Scott KV; Trettien AL; Jonas L; Denerolle P
    J Am Vet Med Assoc; 1993 Feb; 202(3):387-91. PubMed ID: 8440627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Romidepsin and interferon gamma: a novel combination for refractory cutaneous T-cell lymphoma.
    Samimi S; Morrissey K; Anshelevich S; Evans K; Gardner J; Musiek A; Vittorio C; Rook A; Kim E
    J Am Acad Dermatol; 2013 Jan; 68(1):e5-6. PubMed ID: 23244387
    [No Abstract]   [Full Text] [Related]  

  • 37. Interferon alpha and etretinate combination treatment of cutaneous T-cell lymphoma.
    Zachariae H; Thestrup-Pedersen K
    J Invest Dermatol; 1990 Dec; 95(6 Suppl):206S-208S. PubMed ID: 2258637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary Cutaneous Gamma-Delta T-cell Lymphoma: Not an Aggressive Disease in All Cases.
    Khallaayoune M; Grange F; Condamina M; Szablewski V; Guillot B; Dereure O
    Acta Derm Venereol; 2020 Jan; 100(1):adv00035. PubMed ID: 31612963
    [No Abstract]   [Full Text] [Related]  

  • 39. Endocrine side-effects of anti-cancer drugs: the impact of retinoids on the thyroid axis.
    Graeppi-Dulac J; Vlaeminck-Guillem V; Perier-Muzet M; Dalle S; Orgiazzi J
    Eur J Endocrinol; 2014 Jun; 170(6):R253-62. PubMed ID: 24616413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of long-term outcomes of combined modality therapy for cutaneous T-cell lymphoma.
    Duvic M; Apisarnthanarax N; Cohen DS; Smith TL; Ha CS; Kurzrock R
    J Am Acad Dermatol; 2003 Jul; 49(1):35-49. PubMed ID: 12833006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.